febit's miRBase 14 Geniom-Biochip Now With 58 Additional New Sequences Available for Cancer Research
febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in…
febit today announced that an updated version of the company's Geniom Biochip containing 58 new discovered sequences in…
58 neue microRNA (miRNA) Sequenzen konnten im Rahmen einer Studie identifiziert werden, die mit dem Applied Biosystems S…
febit today announced the launch of its HybSelector, a new instrument for high throughput targeted resequencing, at the…
febit stellt in der kommenden Woche auf der 11. Konferenz "Advances in Genome Biology and Technology" (AGBT) in Florida…
The Molecular Genetics Core Facility (MGCF) at Children's Hospital Boston chose febit's HybSelect technology which will…
Die Molecular Genetics Core Facility (MGCF) am Children's Hospital Boston (USA) hat sich für den Einsatz von febit's Hyb…
febit's HybSelect has been recognized as one of the winners of the "Top 10 Innovations of 2009" by The Scientist magazin…
Die HybSelect-Technologie des Heidelberger Biomarker-Spezialisten febit wurde von der Zeitschrift "The Scientist" zu ein…
The Cancer Genomic Microarray Facility at the Kimmel Cancer Center of the Thomas Jefferson University, Philadelphia, sel…
Das Kimmel Krebszentrum der Thomas Jefferson Universität (USA) hat sich für den Geniom® RT Analyzer von febit entschiede…